EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prediction of prognosis and immune checkpoint inhibitor response to anti-PD-1 therapy in patients with metastatic melanoma based on apoptotic cell clearance-related signatures

Yongchang Guo, Yali Wang, Hui Li

Letters in Drug Design & Discovery · 2026-10 · 100648

DOI: 10.1016/j.lddd.2026.100648 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-10. Verfasst von Yongchang Guo und 2 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Guo, Y., Wang, Y., & Li, H. (2026). Prediction of prognosis and immune checkpoint inhibitor response to anti-PD-1 therapy in patients with metastatic melanoma based on apoptotic cell clearance-related signatures. Letters in Drug Design & Discovery, 100648. https://doi.org/10.1016/j.lddd.2026.100648

Vancouver

Guo Y, Wang Y, Li H. Prediction of prognosis and immune checkpoint inhibitor response to anti-PD-1 therapy in patients with metastatic melanoma based on apoptotic cell clearance-related signatures. Letters in Drug Design & Discovery. 2026:100648. doi:10.1016/j.lddd.2026.100648

BibTeX
@article{Guo2026,
  author = {Guo, Yongchang and Wang, Yali and Li, Hui},
  title = {Prediction of prognosis and immune checkpoint inhibitor response to anti-PD-1 therapy in patients with metastatic melanoma based on apoptotic cell clearance-related signatures},
  journal = {Letters in Drug Design & Discovery},
  year = {2026},
  pages = {100648},
  doi = {10.1016/j.lddd.2026.100648}
}
Kostenlos starten →